NO975673L - Standariserte primære osteoblastcellekulturer fra osteoporosepasienter, og deres bruk i diagnostisering av osteoporose og testing av potensielle terapeutiske midler mot osteoporose - Google Patents

Standariserte primære osteoblastcellekulturer fra osteoporosepasienter, og deres bruk i diagnostisering av osteoporose og testing av potensielle terapeutiske midler mot osteoporose

Info

Publication number
NO975673L
NO975673L NO975673A NO975673A NO975673L NO 975673 L NO975673 L NO 975673L NO 975673 A NO975673 A NO 975673A NO 975673 A NO975673 A NO 975673A NO 975673 L NO975673 L NO 975673L
Authority
NO
Norway
Prior art keywords
osteoporosis
cell cultures
potential therapeutic
patients
expression
Prior art date
Application number
NO975673A
Other languages
English (en)
Other versions
NO975673D0 (no
NO322971B1 (no
Inventor
Olivera Josimovic-Alasevic
Karl-Gerd Fritsch
Jochen Ittner
Original Assignee
Codon Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19601052A external-priority patent/DE19601052A1/de
Application filed by Codon Gmbh filed Critical Codon Gmbh
Publication of NO975673D0 publication Critical patent/NO975673D0/no
Publication of NO975673L publication Critical patent/NO975673L/no
Publication of NO322971B1 publication Critical patent/NO322971B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0654—Osteocytes, Osteoblasts, Odontocytes; Bones, Teeth
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/105—Insulin-like growth factors [IGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/15—Transforming growth factor beta (TGF-β)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2503/00—Use of cells in diagnostics

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • Physiology (AREA)
  • Rheumatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO19975673A 1995-06-07 1997-12-05 Fremgangsmate for diagnostisering av osteoporose og testing av potensielle terapeutiske midler mot osteoporose. NO322971B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19521942 1995-06-07
DE19601052A DE19601052A1 (de) 1995-06-07 1996-01-05 Standardisierte, primäre Osteoblastenzellkulturen aus osteoporotischen Patienten und deren Verwendung zur Osteoporosediagnose und zur Testung potentieller Osteoporose-Therapeutika
PCT/DE1996/001042 WO1996040873A1 (de) 1995-06-07 1996-06-07 Standardisierte, primäre osteoblastenzellkulturen aus osteoporotischen patienten und deren verwendung zur osteoporosediagnose und zur testung potentieller osteoporose-therapeutika

Publications (3)

Publication Number Publication Date
NO975673D0 NO975673D0 (no) 1997-12-05
NO975673L true NO975673L (no) 1998-01-30
NO322971B1 NO322971B1 (no) 2006-12-18

Family

ID=26016033

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19975673A NO322971B1 (no) 1995-06-07 1997-12-05 Fremgangsmate for diagnostisering av osteoporose og testing av potensielle terapeutiske midler mot osteoporose.

Country Status (9)

Country Link
US (1) US6713269B2 (no)
EP (1) EP0832195B1 (no)
JP (1) JPH11506010A (no)
AT (1) ATE309330T1 (no)
AU (1) AU733637B2 (no)
CA (1) CA2223101A1 (no)
DE (1) DE59611292D1 (no)
NO (1) NO322971B1 (no)
WO (1) WO1996040873A1 (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19842802A1 (de) * 1998-09-18 2000-03-23 Christoph Geissmaier Kultursystem zur optimierten Anregung des Wachstums und der Differenzierung von Knorpelzellen und/oder von Knochenzellen, Verfahren zur Herstellung des Kultursystems sowie Produkt unter Verwendung des Kultursystems
FR2833270B1 (fr) * 2001-12-10 2004-02-27 Sympathos Modele de developpement osseux
KR100638122B1 (ko) * 2001-12-21 2006-10-24 더 프록터 앤드 갬블 캄파니 골 장애의 치료 방법
WO2007104724A2 (en) * 2006-03-10 2007-09-20 Universitá Degli Studi Di Siena Identification of osteoblast cells differentiation and bone tumor markers and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3560252B2 (ja) 1992-08-28 2004-09-02 アベンティス ファーマ株式会社 骨関連カドヘリン様タンパク質およびその製造法

Also Published As

Publication number Publication date
NO975673D0 (no) 1997-12-05
ATE309330T1 (de) 2005-11-15
AU733637B2 (en) 2001-05-17
AU5996196A (en) 1996-12-30
US6713269B2 (en) 2004-03-30
NO322971B1 (no) 2006-12-18
DE59611292D1 (de) 2005-12-15
CA2223101A1 (en) 1996-12-19
WO1996040873A1 (de) 1996-12-19
EP0832195A1 (de) 1998-04-01
US20020076730A1 (en) 2002-06-20
EP0832195B1 (de) 2005-11-09
JPH11506010A (ja) 1999-06-02

Similar Documents

Publication Publication Date Title
Suzuki et al. Advanced glycation end products in musculoskeletal system and disorders
CANALIS Interleukin-1 has independent effects on deoxyribonucleic acid and collagen synthesis in cultures of rat calvariae
Angele et al. Cyclic hydrostatic pressure enhances the chondrogenic phenotype of human mesenchymal progenitor cells differentiated in vitro
Lee et al. Measurement of osteocalcin
Tesarik et al. Selective expression of a progesterone receptor on the human sperm surface
Apple et al. Early detection of skeletal muscle injury by assay of creatine kinase MM isoforms in serum after acute exercise.
NO963371L (no) Hematopoietisk protein samt materialer og fremgangsmåter for fremstilling av det
Tripathi et al. Osteocalcin and serum insulin-like growth factor-1 as biochemical skeletal maturity indicators
DE69131482D1 (en) Phosphotyrosin phosphatase als neuer rezeptor-typ
Sachdeva et al. Study of some common biochemical bone turnover markers in postmenopausal women
Pan et al. Kinetic of bone turnover markers after osteoporotic vertebral compression fractures in postmenopausal female
Das et al. Keratinocyte growth factor is upregulated by the hyperplasia-inducing drug nifedipine
Visconti et al. A functional three‐dimensional microphysiological human model of myeloma bone disease
NO975673L (no) Standariserte primære osteoblastcellekulturer fra osteoporosepasienter, og deres bruk i diagnostisering av osteoporose og testing av potensielle terapeutiske midler mot osteoporose
Vance et al. A cross-sectional analysis of age related changes in the osteometric dimensions of long bones in modern South Africans of European and African descent
Sidell et al. Immunological aspects of retinoids in humans: I. Analysis of retinoic acid enhancement of thymocyte responses to PHA
Herrmann et al. Accumulation of homocysteine by decreasing concentrations of folate, vitamin B12 and B6 does not influence the activity of human osteoblasts in vitro
Pravitharangul et al. Mandible and iliac osteoblasts exhibit different Wnt signaling responses to LMHF vibration
Piatek et al. Multiparameter analysis of serum levels of C-telopeptide crosslaps, bone-specific alkaline phosphatase, cathepsin K, osteoprotegerin and receptor activator of nuclear factor κB ligand in the diagnosis of osteoporosis
Muneyyirci-Delale et al. Serum ionized magnesium and calcium and sex hormones in healthy young men: importance of serum progesterone level
Johar et al. Application of laser scanning cytometry in vascular smooth muscle remodeling
Iwamoto et al. Use of a reconstituted basement membrane to study the invasiveness of tumor cells
Scheuren Longitudinal assessment of frailty and osteosarcopenia in an in vivo model of premature aging
Ma Adaptation of bone to physical activity and diet-induced obesity
Hoover et al. Proteomic characterization of a trauma-based rat model of heterotopic ossification identifies interactive signaling networks as potential therapeutic targets

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees